Scott Chappell

Scott Chappell is an Associate at Steptoe, where his practice emphasizes patent litigation across various venues, including district courts, the Patent Trial and Appeal Board (PTAB), and Section 337 investigations before the U.S. International Trade Commission. He counsels clients, from Fortune 500 companies to startups, on intellectual property disputes.

His technological expertise spans a wide range of fields, including medical devices, software and machine learning, automotive technologies, industrial machinery, batteries, and robotics. While his single tracked appearance is on the plaintiff side in a medical device patent dispute, his firm's broader practice includes representing both plaintiffs and defendants in patent matters.

A notable case includes his role as counsel for Terumo BCT, Inc. in Terumo BCT, Inc. v. Haemonetics Corp., a patent infringement action filed in the District of Colorado concerning plasma systems. He was also involved in related IPR proceedings (IPR2025-01374, IPR2025-01391), where the USPTO Director denied institution of IPRs, citing the petitioner's inconsistent claim construction arguments between the PTAB and co-pending district court litigation. This demonstrates his active involvement in post-grant proceedings, further highlighted by his contributions to firm blog posts discussing PTAB developments, such as the "Director's Push Against Co-Pending Proceedings."

Mr. Chappell is admitted to practice in the District of Columbia and Massachusetts, and is registered to practice before the U.S. Patent & Trademark Office. He earned his J.D. from Suffolk University Law School and a B.S. in Biomedical Engineering from Boston University School of Engineering.